Search

The article investigates the role of hydrolyzed conchiolin protein (HCP) in inhibiting dendrite formation of melanocytes via Wnt/Β-catenin signaling pathway. The study examined the effects of HCP on endothelin-1 induced melanocyte dendrite formation in PIG1 and MelanA cells and on microphthalmia-associated transcription factor, tyrosinase, Rab27a and Rac1 gene expression related to melanosome transport and melanin transfer. It suggests HCP for possible skin pigmentation disorder treatment.

The high-precision calibration results of the petroleum underground layer are of great significance for oil production efficiency. This study uses the gravity magnetic model to retrieve the bedrock depth. The results of the basement structure and sedimentary rock distribution through the gravity and magnetic geology in the petroleum underground prospect of the Tongbai basin were also obtained. On this basis, the geological data, logging data, seismic data, and the Vertical Seismic Profile (VSP) data has been comprehensively used, as the layered calibration method was used to calibrate the petroleum underground layer. Considering the seismic datum and the core elevation in the area, the rock formation is divided by various logging curves. The average time difference and density of the divided rock layers are interpolated at equal depth intervals to obtain velocity sequences and density sequences at equal time intervals and finally realize time-depth conversion. When the drilling geological horizon is unified, the synthetic record of the seismic reflection layer is compared with the geological horizon to realize the horizon calibration of the seismic reflection layer. When the local stratification is not uniform, the seismic reflection layer is calibrated by tracking the seismic reflection layer, high-precision velocity analysis, and various synthetic records to verify the reliability of the geological horizon. The results show that the proposed method can accurately survey the geological conditions of the Tongbai basin. It detected 14 basement faults, and that the NW-trending and NE-trending faults controlled the basin, while the North-South faults controlled the later evolution of the basin. The method can be used for the horizon calibration of inclined wells, which is suitable not only for anisotropic media but also for formations with a less lateral variation of local formation lithology. Moreover, its usage is flexible, and it can be corrected by multiple speed data. [ABSTRACT FROM AUTHOR]

Background: Brain-derived estrogen is implicated in pain-related aversion; however, which estrogen receptors mediate this effect remains unclear. This study hypothesized that the different estrogen receptors in the rostral anterior cingulate cortex play distinct roles in pain-related aversion.Methods: Formalin-induced conditioned place avoidance and place escape/avoidance paradigms were used to evaluate pain-related aversion in rodents. Immunohistochemistry and Western blotting were used to detect estrogen receptor expression. Patch-clamp recordings were used to examine N-methyl-D-aspartate-mediated excitatory postsynaptic currents in rostral anterior cingulate cortex slices.Results: The administration of the estrogen receptor-β antagonist 4-(2-phenyl-5,7-bis [trifluoromethyl] pyrazolo [1,5-a] pyrimidin-3-yl) phenol (PHTPP) or the G protein-coupled estrogen receptor-1 antagonist (3aS*,4R*,9bR*)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta [c] quinolone (G15) but not the estrogen receptor-α antagonist 1,3-bis (4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy) phenol]-1H-pyrazole dihydrochloride (MPP) into the rostral anterior cingulate cortex blocked pain-related aversion in rats (avoidance score, mean ± SD: 1,3-bis [4-hydroxyphenyl]-4-methyl-5-(4-[2-piperidinylethoxy] phenol)-1H-pyrazole dihydrochloride (MPP): 47.0 ± 18.9%, 4-(2-phenyl-5,7-bis [trifluoromethyl] pyrazolo [1,5-a] pyrimidin-3-yl) phenol (PHTPP): -7.4 ± 20.6%, and [3aS*,4R*,9bR*]-4-[6-bromo-1,3-benzodioxol-5-yl]-3a,4,5,9b-3H-cyclopenta [c] quinolone (G15): -4.6 ± 17.0% vs. vehicle: 46.5 ± 12.2%; n = 7 to 9; P < 0.0001). Consistently, estrogen receptor-β knockdown but not estrogen receptor-α knockdown by short-hairpin RNA also inhibited pain-related aversion in mice (avoidance score, mean ± SD: estrogen receptor-α-short-hairpin RNA: 26.0 ± 7.1% and estrogen receptor-β-short-hairpin RNA: 6.3 ± 13.4% vs. control short-hairpin RNA: 29.1 ± 9.1%; n = 7 to 10; P < 0.0001). Furthermore, the direct administration of the estrogen receptor-β agonist 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN) or the G protein-coupled estrogen receptor-1 agonist (±)-1-([3aR*,4S*,9bS*]-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta [c]quinolin-8-yl)-ethanone (G1) into the rostral anterior cingulate cortex resulted in conditioned place avoidance (avoidance score, mean ± SD: 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN): 35.3 ± 9.5% and (±)-1-([3aR*,4S*,9bS*]-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta [c]quinolin-8-yl)-ethanone (G1): 43.5 ± 22.8% vs. vehicle: 0.3 ± 14.9%; n = 8; P < 0.0001) but did not affect mechanical or thermal sensitivity. The activation of the estrogen receptor-β/protein kinase A or G protein-coupled estrogen receptor-1/protein kinase B pathway elicited the long-term potentiation of N-methyl-D-aspartate-mediated excitatory postsynaptic currents.Conclusions: These findings indicate that estrogen receptor-β and G protein-coupled estrogen receptor-1 but not estrogen receptor-α in the rostral anterior cingulate cortex contribute to pain-related aversion by modulating N-methyl-D-aspartate receptor-mediated excitatory synaptic transmission. [ABSTRACT FROM AUTHOR]

Photo detection of ultraviolet (UV) light remains a challenge since the penetration depth of UV light is limited to the nanometer scale. Therefore, the doping profile and electric field in the top nanometer range of the photo detection devices become critical. Traditional UV photodetectors usually use a constant doping profile near the semiconductor surface, resulting in a negligible electric field, which limits the photo-generated carrier collection efficiency of the photodetector. Here, we demonstrate, via the use of an optimized gradient boron doping technique, that the carrier collection efficiency and photo responsivity under the UV wavelength region have been enhanced. Furthermore, the ultrathin p+-i-n junction shows an avalanche gain of 2800 and an ultra-low junction capacitance (sub pico-farad), indicating potential applications in the low timing jitter single photon detection area. [ABSTRACT FROM AUTHOR]

An integrated Ge photodetector of very low dark current density is demonstrated in an optoelectronic integrated circuit label-free biosensing system. The sensor system consists of a microring for optical sensing and a monolithically integrated Ge detector. For point-of-care applications, integration of Ge detector increases the reliability of measurement by eliminating mechanical-optical alignment of output signals. Optimizing Ge detector performance will further enhance system signal-noise ratio and reliability. For homogeneous sensing, the system has a sensitivity of ~ 18. 8 nm/RIU and a detection limit of 3.50 × 10-5. [ABSTRACT FROM AUTHOR]

Objective: The mainstay treatment of esophageal squamous cell carcinoma (ESCC) involves chemotherapy and immunotherapy. However, alternative therapies are required for patients who are refractory or intolerant to existing therapies. Methods: In this single-arm, multicenter, open-label phase Ib study, 30 patients received an intravenous infusion of SCT200, an antiepidermal growth factor receptor (EGFR) monoclonal antibody, 6.0 mg/kg once a week for 6 weeks, followed by 8.0 mg/kg once every 2 weeks until disease progression or intolerable toxicity. The primary endpoint was the objective response rate (ORR). The secondary endpoints were progression-free survival (PFS), overall survival (OS), and safety. Results: Thirty patients were enrolled between July 2018 and May 2019. The ORR was 16.7% (95% CI: 5.6%-34.7%). The median PFS and OS were 3.1 months (95% CI: 1.5-4.3) and 6.8 months (95% CI: 4.7-10.1), respectively. A numerical difference without any statistical significance in ORR was observed in patients with different EGFR expressions (≥ 50%: 25.0% vs. < 50%: 0%, P = 0.140) or TP53 mutation abundance (< 10%: 23.8% vs. ≥ 10%: 0%, P = 0.286). Improved median PFS (3.4 vs. 1.4 months, P = 0.006) and OS (8.0 vs. 4.2 months, P = 0.027) were associated with TP53 mutation abundance of < 10%. The most common treatment-related adverse events of grade 3 or 4 (occurring in ≥ 2 patients) were hypomagnesemia [7 (23.3%)] and rash [2 (6.7%)]. No treatmentrelated death occurred. Conclusions: SCT200 monotherapy as the second- or further-line treatment for advanced ESCC showed favorable efficacy, with an acceptable safety profile. TP53 mutation abundance might serve as a potential predictive biomarker. [ABSTRACT FROM AUTHOR]